Brett Fishbin Analyst Performance

Brett Fishbin is a stock analyst at KeyCorp focused in the medical sector, covering 8 publicly traded companies. Over the past year, Brett Fishbin has issued 13 stock ratings, including buy and hold recommendations. While full access to Brett Fishbin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brett Fishbin's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

13 Last 0 Years

Buy Recommendations

83.33% 10 Buy Ratings

Companies Covered

8 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	83.3%	10 ratings
Hold	16.7%	2 ratings
Sell	0.0%	0 ratings

Out of 12 total stock ratings issued by Brett Fishbin at KeyCorp, the majority (83.3%) have been Buy recommendations, followed by 16.7% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NYSE	75.0% of companies on NYSE	6 companies
NASDAQ	25.0% of companies on NASDAQ	2 companies

Brett Fishbin, an analyst at KeyCorp, currently covers 8 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 6 companies	75.0%
	Computer and Technology 2 companies	25.0%

Brett Fishbin of KeyCorp specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.

Coverage Industries

Industry	Percentage
MED INSTRUMENTS 3 companies	37.5%
MEDICAL INFO SYS 1 company	12.5%
MED PRODUCTS 1 company	12.5%
MEDICAL SERVICES 1 company	12.5%
SEMI - GENERAL 1 company	12.5%
COMP - SOFTWARE 1 company	12.5%

About Brett Fishbin

Brett Fishbin is a Vice President and Equity Research Analyst for KeyBanc Capital Markets Inc. With the firm since 2017, he focuses his research on the Medical Technology sector. Before his promotion to senior analyst, he was a Research Associate on KBCM’s healthcare team for six years, including five in MedTech. Brett's previous investment experience includes actively managing a portion of the University of Wisconsin’s endowment fund as part of the Applied Securities Program, as well as an internship at Heartland Advisors in Milwaukee. Fishbin earned a Bachelor of Business Administration in finance and an master's degree in Applied Securities Analysis from the University of Wisconsin-Madison. He also holds the Series 7, 63, 86, and 87 industry certifications.

Follow on LinkedIn

Brett Fishbin's Ratings History at KeyCorp

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
INSP Inspire Medical Systems	8/5/2025	Downgrade	$130.79		Sector Weight	$0.00 00.00% ROI
RMD ResMed	8/1/2025	Boost Price Target	$272.16	$298.00	Overweight	$0.00 00.00% ROI
STE STERIS	7/22/2025	Boost Price Target	$223.65	$288.00	Overweight	$0.00 00.00% ROI
INSP Inspire Medical Systems	7/22/2025	Lower Price Target	$128.10	$197.00	Overweight	$0.00 00.00% ROI
SOLV Solventum	6/6/2025	Initiated Coverage	$75.28		Sector Weight	$0.00 00.00% ROI
RMD ResMed	4/24/2025	Set Price Target	$232.12	$274.00		$0.00 00.00% ROI
TXN Texas Instruments	4/24/2025	Lower Price Target	$160.82	$215.00	Overweight	$0.00 00.00% ROI
ALC Alcon	3/31/2025	Boost Price Target	$94.59	$112.00	Overweight	$0.00 00.00% ROI
RMD ResMed	1/31/2025	Boost Price Target	$242.87	$280.00	Overweight	$0.00 00.00% ROI
SLP Simulations Plus	1/24/2025	Boost Price Target	$33.96	$37.00	Overweight	$0.00 00.00% ROI
ITGR Integer	1/24/2025	Boost Price Target	$143.32	$154.00	Overweight	$0.00 00.00% ROI
INSP Inspire Medical Systems	1/24/2025	Reiterated Rating	$185.53	$234.00	Overweight	$0.00 00.00% ROI
ALC Alcon	1/24/2025	Lower Price Target	$89.24	$105.00	Overweight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.